Published 11 days ago • loading... • Updated 5 days ago

DOD commits $9.8 million to study psychedelics for active-duty troops

Walter Reed National Military Medical Center will receive a $4.9 million grant from the Department of Defense to study MDMA's effects on psychological flexibility in soldiers with PTSD, as confirmed by officials.
The study will be led by Aaron Wolfgang, involving 91 active-duty service members undergoing multiple MDMA sessions over 10 months.
Veteran Jonathan Lubecky noted that MDMA-assisted therapy helped him cope with trauma and advocated for immediate treatment for service members.
Wolfgang emphasized the importance of offering cutting-edge therapy to those who sacrifice in service to the country.

Insights by Ground AI

Does this summary seem wrong?

20 Articles

All

Left

Center

Right

Vail Daily

Center

Vail Health’s pioneering study of psilocybin’s effects on depression kicks off next month

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ingredient in psychedelic mushrooms, on people with major depressive disorder. In preparation for the study, Vail Health held a discussion on the OPTIMIZE study and the impacts of psilocybin on one woman’s life on Monday, March 3, at Colorado Mount…

8 days ago

Read Full Article

Radio Iowa

Center

Bill would O.K. synthetic psilocybin prescriptions in Iowa, if FDA clears use - Radio Iowa

A bill under consideration in the legislature would position Iowa to immediately allow prescriptions of a synthetic version of psychedelic mushrooms if it gains FDA approval. Psilocybin is a naturally occurring compound found in so-called “magic mushrooms.” Christopher Rants is a lobbyist for Compass Pathways, a pharmaceutical firm that’s developed a synthetic form of psilocybin […]

9 days ago

Read Full Article

Reason Foundation

Lean Right

Exploring new data on the safety of psychedelics

Prior to his confirmation, the new head of Health and Human Services, Robert F. Kennedy Jr., indicated he wanted sweeping reforms to federal drug policy and was “open” to improving access to psychedelics. Among the most promising reforms on the table is the potential reclassification of psilocybin, the active compound in “magic mushrooms,” from its current status as a Schedule I substance banned under the Controlled Substances Act (CSA). Under t…

9 days ago

Read Full Article

Nevada Independent

Center

Waiting for the feds is a horrible strategy for psychedelics - The Nevada Independent

If we decide to wait for the federal government to take the lead, the “psychedelic renaissance” isn’t going to be coming to Nevada any time soon. Last week, the Senate Legislative Operations and Elections Committee heard SJR10, a resolution calling on federal agencies to recategorize psychedelic compounds such as methylenedioxymethamphetamine (MDMA) and psilocybin (magic mushrooms) to allow for potential therapeutic uses. While that resolution…

9 days ago

Read Full Article

CBS News

+3 Reposted by 3 other sources

Lean Left

The Colorado psychedelic mushroom experiment has arrived

With the first licenses for providing psychedelic mushrooms issued in Colorado, excitement and questions build about the fungi's potential, affordability and safety.

10 days ago

Read Full Article

Narratively

Lean Left

Our Therapist Gave My Wife and Me MDMA—and It Saved Our Marriage

Listen now: Julianna and I were on the brink of breaking up when we were met with an unexpected proposal that changed the way we saw ourselves and each other, forever.

10 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year